Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guben Kechuan Jiaonang (天力可致固本咳喘胶囊) is a traditional Chinese medicine (TCM) hard capsule indicated for the treatment of chronic bronchitis presenting with symptoms such as cough, excessive phlegm, shortness of breath, and severe asthma upon exertion. Its therapeutic actions are based on TCM principles, aiming to benefit Qi, consolidate the exterior, strengthen the spleen, and tonify the kidney. The formulation addresses conditions arising from spleen deficiency with phlegm exuberance and unstable kidney qi. It is composed of several herbal ingredients including Codonsis Radix, Atractylodes Macrocephala, Poria, Ophiopogon Japonicus, vinegar-processed Schisandra Chinensis, honey-processed Glycyrrhiza Uralensis, and salt water stir-fried Psoralea Corylifolia. This non-prescription drug is manufactured by Hefei Jinyue Pharmaceutical Co., Ltd.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guben Kechuan Jiaonang.